Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats

NeuroReport

Volumn 11, Issue 4, 2000, Pages 829-832

  Lu, Lin ^a,b   Huang, Mingsheng ^a   Liu, Zhiyuan ^a   Ma, Lan ^b  

^a SICHUAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Agonist; Antagonist; Cholecystokinin; Extinction; Morphine dependence; Withdrawal

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CERULETIDE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DEVAZEPIDE; MORPHINE; NALOXONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; MALE; MORPHINE ADDICTION; NONHUMAN; PATHOGENESIS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SYMPTOM; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 0034689188     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200003200-00034     Document Type: Article

References (19)

1. 1. Such HH, Collins and Tseng F. Neuropeptides 21, 131-136 (1992).
2. 2. Hill RG, Hughes J and Pittaway KM. Neuropharmacol 26, 289-300 (1987).
3. 3. Wang RY, White FJ and Voigt MM. Trends Pharmacol Sci 5, 436-438 (1984).
4. 4. Zarrindast MA, Malekzadeh A, Rezayat M et al. Pharmacol Toxicol 77, 360-364 (1995).
5. 5. Meister B, Villar MJ, Ceccatelli S et al. Neuroscience 37, 603-633 (1990).
6. 6. Honda T, Wada E, Battey JF et al. Mol Cell Neurosci 4, 143-154 (1993).
7. 7. Dourish CT, Hawley D and Iversen D. Eur J Pharmacol 147, 469-472 (1988).
8. 8. Dourish CT, O'Neil MF, Coughlan J et al. Eur J Pharmacol 176, 35-44 (1990).
9. 9. Devries TJ, Schoffelmeer AN, Binnekade R et al. Eur J Neurosci 10, 3565-3571 (1998).
10. 10. Lu L, Huang MS, Li J et al. Chin J Med 72, 125-126 (1999).
11. 11. Maldonado R, Saiardi A, Valverde O et al. Nature 388, 586-589 (1997).
12. 12. Kratzer U and Schmidt WJ. Neurosci 252, 53-56 (1998).
13. 13. Rezayat M, Azizi N and Zarrindast MR et al. Pharmacol Toxicol 81, 124-129 (1997).
14. 14. Noble F and Roques BP. Prog Neurobiol 58, 349-379 (1999).
15. 15. Crespi F. Methods Find Exp Clin Pharmacol 20, 679-697 (1998).
16. 16. Popik P and Danysz W. J Pharmacol Exp Ther 280, 854-865 (1997).
17. 17. Spanagel R, Sillaber I, Zieglgansberger W et al. Psychopharmacology 139, 391-401 (1998).
18. 18. Maldonado R, Valverde O, Ducos B et al. Br J Pharmacol 114, 1031-1039 (1995).
19. 19. Roques BP and Noble F. Neurochem Res 21, 1395-1409 (1996).